Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00804258 · ClinicalTrials.gov registry record
Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer
A clinical trial, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- 17
- Enrollment target
NCT00804258: Completed study, sponsored by City of Hope Medical Center.
NCT00804258 is a clinical trial that has completed, run by City of Hope Medical Center. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00804258 has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
RATIONALE: Palliative care may help improve the quality of life of patients with ovarian cancer who are undergoing intraperitoneal chemotherapy. PURPOSE: This clinical trial is studying palliative care in patients with ovarian cancer who are undergoing intraperitoneal chemotherapy.
Interventions
- OTHER medical chart review
- OTHER questionnaire administration
- OTHER educational intervention
- PROCEDURE assessment of therapy complications
- DRUG intraperitoneal chemotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2007-08 |
| Est. Completion | 2012-01 |
What the finished NCT00804258 record still lists
NCT00804258 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 5 interventions - of which medical chart review is the first listed.
NCT00804258 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00804258 about?
NCT00804258 is a clinical study titled "Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer". RATIONALE: Palliative care may help improve the quality of life of patients with ovarian cancer who are undergoing intraperitoneal chemotherapy. PURPOSE: This clinical trial is studying palliative care in patients with ovarian cancer who are undergoing intraperitoneal chemotherapy.
What is the current status of trial NCT00804258?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2007-08. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00804258?
The interventions under investigation include: medical chart review (OTHER), questionnaire administration (OTHER), educational intervention (OTHER), assessment of therapy complications (PROCEDURE), intraperitoneal chemotherapy (DRUG).
Who is sponsoring clinical trial NCT00804258?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia